APO Research, Inc.

APO RESEARCH · REPORT

Nootropic Food Ingredients

Selected research

Market Outlook & Growth Opportunities

Global Nootropic Food Ingredients Market Outlook and Growth Opportunities 2026

Market perspective

The global Nootropic Food Ingredients market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Nootropic Food Ingredients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nootropic Food Ingredients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nootropic Food Ingredients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Nootropic Food Ingredients market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Nootropic Food Ingredients market include Lonza Group, DSM Firmenich, Glanbia Nutritionals, Kerry Group, Ingredion Inc, Cargill Inc, Indena S.p.A, Sabinsa Corporation and Balchem Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Nootropic Food Ingredients market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nootropic Food Ingredients and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nootropic Food Ingredients sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nootropic Food Ingredients market size, projected growth trends, production technologies, key applications, and end-use industries.

Nootropic Food Ingredients Segment by Company

Lonza Group

DSM Firmenich

Glanbia Nutritionals

Kerry Group

Ingredion Inc

Cargill Inc

Indena S.p.A

Sabinsa Corporation

Balchem Corporation

Givaudan

Arla Food Ingredients

PLT Health Solutions

Natreon

Kyowa Hakko Bio Co., Ltd

Archer Daniels Midland

BASF SE

Kemin Corporation

Ixoreal Biomed

Beijing Gingko Group

Wuxi Cima Science Co., Ltd.

Nootropic Food Ingredients Segment by Type

Amino Acids and Derivatives

Botanical Extracts

Vitamins and Minerals

Synthetic Nootropis

Others

Nootropic Food Ingredients Segment by Application

Dietary Supplements

Functional Food and Beverages

Sport Nutrition

Clinical and Medical Nutrition

Others

Nootropic Food Ingredients Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Nootropic Food Ingredients status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Nootropic Food Ingredients market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Nootropic Food Ingredients significant trends, drivers, influence factors in global and regions.

6. To analyze Nootropic Food Ingredients competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nootropic Food Ingredients market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nootropic Food Ingredients and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nootropic Food Ingredients.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nootropic Food Ingredients market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nootropic Food Ingredients industry.

Chapter 3: Detailed analysis of Nootropic Food Ingredients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Nootropic Food Ingredients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Nootropic Food Ingredients in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Nootropic Food Ingredients Industry Trends Table 2. Nootropic Food Ingredients Industry Drivers Table 3. Nootropic Food Ingredients Industry Opportunities and Challenges Table 4. Nootropic Food Ingredients Industry Restraints Table 5. Global Nootropic Food Ingredients Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Nootropic Food Ingredients Revenue Share by Company (2021-2026) Table 7. Global Nootropic Food Ingredients Sales Volume by Company (t) & (2021-2026) Table 8. Global Nootropic Food Ingredients Sales Volume Share by Company (2021-2026) Table 9. Global Nootropic Food Ingredients Average Price (USD/t) of Company (2021-2026) Table 10. Global Nootropic Food Ingredients Company Ranking, (2024-2026) & (USD Million) Table 11. Global Nootropic Food Ingredients Key Company Manufacturing Base & Headquarters Table 12. Global Nootropic Food Ingredients Company, Product Type & Application Table 13. Global Nootropic Food Ingredients Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Nootropic Food Ingredients by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Amino Acids and Derivatives Table 18. Significant Companies of Botanical Extracts Table 19. Significant Companies of Vitamins and Minerals Table 20. Significant Companies of Synthetic Nootropis Table 21. Significant Companies of Others Table 22. Global Nootropic Food Ingredients Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 23. Global Nootropic Food Ingredients Sales Volume by Type (2021-2026) & (t) Table 24. Global Nootropic Food Ingredients Sales Volume by Type (2027-2032) & (t) Table 25. Global Nootropic Food Ingredients Sales Volume Share by Type (2021-2026) Table 26. Global Nootropic Food Ingredients Sales Volume Share by Type (2027-2032) Table 27. Global Nootropic Food Ingredients Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Nootropic Food Ingredients Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Nootropic Food Ingredients Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Nootropic Food Ingredients Sales Value Share by Type (2021-2026) Table 31. Global Nootropic Food Ingredients Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Dietary Supplements Table 33. Significant Companies of Functional Food and Beverages Table 34. Significant Companies of Sport Nutrition Table 35. Significant Companies of Clinical and Medical Nutrition Table 36. Significant Companies of Others Table 37. Global Nootropic Food Ingredients Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 38. Global Nootropic Food Ingredients Sales Volume by Application (2021-2026) & (t) Table 39. Global Nootropic Food Ingredients Sales Volume by Application (2027-2032) & (t) Table 40. Global Nootropic Food Ingredients Sales Volume Share by Application (2021-2026) Table 41. Global Nootropic Food Ingredients Sales Volume Share by Application (2027-2032) Table 42. Global Nootropic Food Ingredients Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Nootropic Food Ingredients Sales Value by Application (2021-2026) & (US$ Million) Table 44. Global Nootropic Food Ingredients Sales Value by Application (2027-2032) & (US$ Million) Table 45. Global Nootropic Food Ingredients Sales Value Share by Application (2021-2026) Table 46. Global Nootropic Food Ingredients Sales Value Share by Application (2027-2032) Table 47. Global Nootropic Food Ingredients Sales by Region: 2021 VS 2025 VS 2032 (t) Table 48. Global Nootropic Food Ingredients Sales by Region (2021-2026) & (t) Table 49. Global Nootropic Food Ingredients Sales Market Share by Region (2021-2026) Table 50. Global Nootropic Food Ingredients Sales by Region (2027-2032) & (t) Table 51. Global Nootropic Food Ingredients Sales Market Share by Region (2027-2032) Table 52. Global Nootropic Food Ingredients Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Nootropic Food Ingredients Sales Value by Region (2021-2026) & (US$ Million) Table 54. Global Nootropic Food Ingredients Sales Value Share by Region (2021-2026) Table 55. Global Nootropic Food Ingredients Sales Value by Region (2027-2032) & (US$ Million) Table 56. Global Nootropic Food Ingredients Sales Value Share by Region (2027-2032) Table 57. Global Nootropic Food Ingredients Market Average Price (USD/t) by Region (2021-2026) Table 58. Global Nootropic Food Ingredients Market Average Price (USD/t) by Region (2027-2032) Table 59. Global Nootropic Food Ingredients Sales by Country: 2021 VS 2025 VS 2032 (t) Table 60. Global Nootropic Food Ingredients Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Nootropic Food Ingredients Sales by Country (2021-2026) & (t) Table 62. Global Nootropic Food Ingredients Sales Market Share by Country (2021-2026) Table 63. Global Nootropic Food Ingredients Sales by Country (2027-2032) & (t) Table 64. Global Nootropic Food Ingredients Sales Market Share by Country (2027-2032) Table 65. Global Nootropic Food Ingredients Sales Value by Country (2021-2026) & (US$ Million) Table 66. Global Nootropic Food Ingredients Sales Value Market Share by Country (2021-2026) Table 67. Global Nootropic Food Ingredients Sales Value by Country (2027-2032) & (US$ Million) Table 68. Global Nootropic Food Ingredients Sales Value Market Share by Country (2027-2032) Table 69. Lonza Group Company Information Table 70. Lonza Group Business Overview Table 71. Lonza Group Nootropic Food Ingredients Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 72. Lonza Group Nootropic Food Ingredients Product Portfolio Table 73. Lonza Group Recent Development Table 74. DSM Firmenich Company Information Table 75. DSM Firmenich Business Overview Table 76. DSM Firmenich Nootropic Food Ingredients Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 77. DSM Firmenich Nootropic Food Ingredients Product Portfolio Table 78. DSM Firmenich Recent Development Table 79. Glanbia Nutritionals Company Information Table 80. Glanbia Nutritionals Business Overview Table 81. Glanbia Nutritionals Nootropic Food Ingredients Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 82. Glanbia Nutritionals Nootropic Food Ingredients Product Portfolio Table 83. Glanbia Nutritionals Recent Development Table 84. Kerry Group Company Information Table 85. Kerry Group Business Overview Table 86. Kerry Group Nootropic Food Ingredients Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 87. Kerry Group Nootropic Food Ingredients Product Portfolio Table 88. Kerry Group Recent Development Table 89. Ingredion Inc Company Information Table 90. Ingredion Inc Business Overview Table 91. Ingredion Inc Nootropic Food Ingredients Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 92. Ingredion Inc Nootropic Food Ingredients Product Portfolio Table 93. Ingredion Inc Recent Development Table 94. Cargill Inc Company Information Table 95. Cargill Inc Business Overview Table 96. Cargill Inc Nootropic Food Ingredients Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 97. Cargill Inc Nootropic Food Ingredients Product Portfolio Table 98. Cargill Inc Recent Development Table 99. Indena S.p.A Company Information Table 100. Indena S.p.A Business Overview Table 101. Indena S.p.A Nootropic Food Ingredients Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 102. Indena S.p.A Nootropic Food Ingredients Product Portfolio Table 103. Indena S.p.A Recent Development Table 104. Sabinsa Corporation Company Information Table 105. Sabinsa Corporation Business Overview Table 106. Sabinsa Corporation Nootropic Food Ingredients Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 107. Sabinsa Corporation Nootropic Food Ingredients Product Portfolio Table 108. Sabinsa Corporation Recent Development Table 109. Balchem Corporation Company Information Table 110. Balchem Corporation Business Overview Table 111. Balchem Corporation Nootropic Food Ingredients Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 112. Balchem Corporation Nootropic Food Ingredients Product Portfolio Table 113. Balchem Corporation Recent Development Table 114. Givaudan Company Information Table 115. Givaudan Business Overview Table 116. Givaudan Nootropic Food Ingredients Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 117. Givaudan Nootropic Food Ingredients Product Portfolio Table 118. Givaudan Recent Development Table 119. Arla Food Ingredients Company Information Table 120. Arla Food Ingredients Business Overview Table 121. Arla Food Ingredients Nootropic Food Ingredients Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 122. Arla Food Ingredients Nootropic Food Ingredients Product Portfolio Table 123. Arla Food Ingredients Recent Development Table 124. PLT Health Solutions Company Information Table 125. PLT Health Solutions Business Overview Table 126. PLT Health Solutions Nootropic Food Ingredients Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 127. PLT Health Solutions Nootropic Food Ingredients Product Portfolio Table 128. PLT Health Solutions Recent Development Table 129. Natreon Company Information Table 130. Natreon Business Overview Table 131. Natreon Nootropic Food Ingredients Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 132. Natreon Nootropic Food Ingredients Product Portfolio Table 133. Natreon Recent Development Table 134. Kyowa Hakko Bio Co., Ltd Company Information Table 135. Kyowa Hakko Bio Co., Ltd Business Overview Table 136. Kyowa Hakko Bio Co., Ltd Nootropic Food Ingredients Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 137. Kyowa Hakko Bio Co., Ltd Nootropic Food Ingredients Product Portfolio Table 138. Kyowa Hakko Bio Co., Ltd Recent Development Table 139. Archer Daniels Midland Company Information Table 140. Archer Daniels Midland Business Overview Table 141. Archer Daniels Midland Nootropic Food Ingredients Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 142. Archer Daniels Midland Nootropic Food Ingredients Product Portfolio Table 143. Archer Daniels Midland Recent Development Table 144. BASF SE Company Information Table 145. BASF SE Business Overview Table 146. BASF SE Nootropic Food Ingredients Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 147. BASF SE Nootropic Food Ingredients Product Portfolio Table 148. BASF SE Recent Development Table 149. Kemin Corporation Company Information Table 150. Kemin Corporation Business Overview Table 151. Kemin Corporation Nootropic Food Ingredients Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 152. Kemin Corporation Nootropic Food Ingredients Product Portfolio Table 153. Kemin Corporation Recent Development Table 154. Ixoreal Biomed Company Information Table 155. Ixoreal Biomed Business Overview Table 156. Ixoreal Biomed Nootropic Food Ingredients Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 157. Ixoreal Biomed Nootropic Food Ingredients Product Portfolio Table 158. Ixoreal Biomed Recent Development Table 159. Beijing Gingko Group Company Information Table 160. Beijing Gingko Group Business Overview Table 161. Beijing Gingko Group Nootropic Food Ingredients Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 162. Beijing Gingko Group Nootropic Food Ingredients Product Portfolio Table 163. Beijing Gingko Group Recent Development Table 164. Wuxi Cima Science Co., Ltd. Company Information Table 165. Wuxi Cima Science Co., Ltd. Business Overview Table 166. Wuxi Cima Science Co., Ltd. Nootropic Food Ingredients Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 167. Wuxi Cima Science Co., Ltd. Nootropic Food Ingredients Product Portfolio Table 168. Wuxi Cima Science Co., Ltd. Recent Development Table 169. Key Raw Materials Table 170. Raw Materials Key Suppliers Table 171. Nootropic Food Ingredients Distributors List Table 172. Nootropic Food Ingredients Customers List Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources Table 176. Primary Sources List of Figures Figure 1. Nootropic Food Ingredients Product Image Figure 2. Global Nootropic Food Ingredients Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nootropic Food Ingredients Sales Value (2021-2032) & (US$ Million) Figure 4. Global Nootropic Food Ingredients Sales (2021-2032) & (t) Figure 5. Global Nootropic Food Ingredients Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Nootropic Food Ingredients Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Amino Acids and Derivatives Image Figure 10. Botanical Extracts Image Figure 11. Vitamins and Minerals Image Figure 12. Synthetic Nootropis Image Figure 13. Others Image Figure 14. Global Nootropic Food Ingredients Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 15. Global Nootropic Food Ingredients Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Nootropic Food Ingredients Sales Volume Share by Type (2021-2032) Figure 17. Global Nootropic Food Ingredients Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Nootropic Food Ingredients Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Nootropic Food Ingredients Sales Value Share by Type (2021-2032) Figure 20. Dietary Supplements Image Figure 21. Functional Food and Beverages Image Figure 22. Sport Nutrition Image Figure 23. Clinical and Medical Nutrition Image Figure 24. Others Image Figure 25. Global Nootropic Food Ingredients Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 26. Global Nootropic Food Ingredients Sales Volume Share 2021 VS 2025 VS 2032 Figure 27. Global Nootropic Food Ingredients Sales Volume Share by Application (2021-2032) Figure 28. Global Nootropic Food Ingredients Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Nootropic Food Ingredients Sales Value Share 2021 VS 2025 VS 2032 Figure 30. Global Nootropic Food Ingredients Sales Value Share by Application (2021-2032) Figure 31. Global Nootropic Food Ingredients Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 32. Global Nootropic Food Ingredients Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. Global Nootropic Food Ingredients Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 34. Global Nootropic Food Ingredients Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America Nootropic Food Ingredients Sales Value (2021-2032) & (US$ Million) Figure 36. North America Nootropic Food Ingredients Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Europe Nootropic Food Ingredients Sales Value (2021-2032) & (US$ Million) Figure 38. Europe Nootropic Food Ingredients Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Asia-Pacific Nootropic Food Ingredients Sales Value (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Nootropic Food Ingredients Sales Value Share by Country (%), 2025 VS 2032 Figure 41. South America Nootropic Food Ingredients Sales Value (2021-2032) & (US$ Million) Figure 42. South America Nootropic Food Ingredients Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Middle East & Africa Nootropic Food Ingredients Sales Value (2021-2032) & (US$ Million) Figure 44. Middle East & Africa Nootropic Food Ingredients Sales Value Share by Country (%), 2025 VS 2032 Figure 45. USA Nootropic Food Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. USA Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. USA Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Canada Nootropic Food Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Canada Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Canada Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Mexico Nootropic Food Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Mexico Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Mexico Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Germany Nootropic Food Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Germany Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Germany Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. France Nootropic Food Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. France Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. France Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. U.K. Nootropic Food Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. U.K. Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. U.K. Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Italy Nootropic Food Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Italy Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Italy Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Spain Nootropic Food Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Spain Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Spain Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Russia Nootropic Food Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Russia Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Russia Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Netherlands Nootropic Food Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Netherlands Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Netherlands Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Nordic Countries Nootropic Food Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Nordic Countries Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Nordic Countries Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. China Nootropic Food Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. China Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. China Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Japan Nootropic Food Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Japan Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Japan Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. South Korea Nootropic Food Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. South Korea Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. South Korea Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. India Nootropic Food Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. India Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. India Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Australia Nootropic Food Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Australia Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Australia Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Southeast Asia Nootropic Food Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Southeast Asia Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Southeast Asia Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Brazil Nootropic Food Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Brazil Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Brazil Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Argentina Nootropic Food Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Argentina Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Argentina Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Chile Nootropic Food Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Chile Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Chile Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Colombia Nootropic Food Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Colombia Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Colombia Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Peru Nootropic Food Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Peru Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Peru Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Nootropic Food Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Saudi Arabia Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Israel Nootropic Food Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Israel Arabia Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Israel Arabia Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. UAE Nootropic Food Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. UAE Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. UAE Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Turkey Nootropic Food Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Turkey Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Turkey Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Iran Nootropic Food Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Iran Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Iran Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Egypt Nootropic Food Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Egypt Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Egypt Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. Nootropic Food Ingredients Value Chain Figure 130. Manufacturing Cost Structure Figure 131. Nootropic Food Ingredients Sales Mode & Process Figure 132. Direct Comparison with Distribution Share Figure 133. Distributors Profiles Figure 134. Years Considered Figure 135. Research Process Figure 136. Key Executives Interviewed

Scope & coverage.

Types
  • Amino Acids and Derivatives
  • Botanical Extracts
  • Vitamins and Minerals
  • Synthetic Nootropis
  • Others
Applications
  • Dietary Supplements
  • Functional Food and Beverages
  • Sport Nutrition
  • Clinical and Medical Nutrition
  • Others
Companies covered
  • Lonza Group
  • DSM Firmenich
  • Glanbia Nutritionals
  • Kerry Group
  • Ingredion Inc
  • Cargill Inc
  • Indena S.p.A
  • Sabinsa Corporation
  • Balchem Corporation
  • Givaudan
  • Arla Food Ingredients
  • PLT Health Solutions
  • Natreon
  • Kyowa Hakko Bio Co., Ltd
  • Archer Daniels Midland
  • BASF SE
  • Kemin Corporation
  • Ixoreal Biomed
  • Beijing Gingko Group
  • Wuxi Cima Science Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nootropic Food Ingredients Sales Value (2021-2032)
  4. 1.2.2 Global Nootropic Food Ingredients Sales Volume (2021-2032)
  5. 1.2.3 Global Nootropic Food Ingredients Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Nootropic Food Ingredients Market Dynamics
  1. 2.1 Nootropic Food Ingredients Industry Trends
  2. 2.2 Nootropic Food Ingredients Industry Drivers
  3. 2.3 Nootropic Food Ingredients Industry Opportunities and Challenges
  4. 2.4 Nootropic Food Ingredients Industry Restraints
3 Nootropic Food Ingredients Market by Company
  1. 3.1 Global Nootropic Food Ingredients Company Revenue Ranking in 2025
  2. 3.2 Global Nootropic Food Ingredients Revenue by Company (2021-2026)
  3. 3.3 Global Nootropic Food Ingredients Sales Volume by Company (2021-2026)
  4. 3.4 Global Nootropic Food Ingredients Average Price by Company (2021-2026)
  5. 3.5 Global Nootropic Food Ingredients Company Ranking (2024-2026)
  6. 3.6 Global Nootropic Food Ingredients Company Manufacturing Base and Headquarters
  7. 3.7 Global Nootropic Food Ingredients Company Product Type and Application
  8. 3.8 Global Nootropic Food Ingredients Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Nootropic Food Ingredients Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Nootropic Food Ingredients Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Nootropic Food Ingredients Market by Type
  1. 4.1 Nootropic Food Ingredients Type Introduction
  2. 4.1.1 Amino Acids and Derivatives
  3. 4.1.2 Botanical Extracts
  4. 4.1.3 Vitamins and Minerals
  5. 4.1.4 Synthetic Nootropis
  6. 4.1.5 Others
  7. 4.2 Global Nootropic Food Ingredients Sales Volume by Type
  8. 4.2.1 Global Nootropic Food Ingredients Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Nootropic Food Ingredients Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Nootropic Food Ingredients Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Nootropic Food Ingredients Sales Value by Type
  12. 4.3.1 Global Nootropic Food Ingredients Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Nootropic Food Ingredients Sales Value by Type (2021-2032)
  14. 4.3.3 Global Nootropic Food Ingredients Sales Value Share by Type (2021-2032)
5 Nootropic Food Ingredients Market by Application
  1. 5.1 Nootropic Food Ingredients Application Introduction
  2. 5.1.1 Dietary Supplements
  3. 5.1.2 Functional Food and Beverages
  4. 5.1.3 Sport Nutrition
  5. 5.1.4 Clinical and Medical Nutrition
  6. 5.1.5 Others
  7. 5.2 Global Nootropic Food Ingredients Sales Volume by Application
  8. 5.2.1 Global Nootropic Food Ingredients Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Nootropic Food Ingredients Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Nootropic Food Ingredients Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Nootropic Food Ingredients Sales Value by Application
  12. 5.3.1 Global Nootropic Food Ingredients Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Nootropic Food Ingredients Sales Value by Application (2021-2032)
  14. 5.3.3 Global Nootropic Food Ingredients Sales Value Share by Application (2021-2032)
6 Nootropic Food Ingredients Regional Sales and Value Analysis
  1. 6.1 Global Nootropic Food Ingredients Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nootropic Food Ingredients Sales by Region (2021-2032)
  3. 6.2.1 Global Nootropic Food Ingredients Sales by Region: 2021-2026
  4. 6.2.2 Global Nootropic Food Ingredients Sales by Region (2027-2032)
  5. 6.3 Global Nootropic Food Ingredients Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Nootropic Food Ingredients Sales Value by Region (2021-2032)
  7. 6.4.1 Global Nootropic Food Ingredients Sales Value by Region: 2021-2026
  8. 6.4.2 Global Nootropic Food Ingredients Sales Value by Region (2027-2032)
  9. 6.5 Global Nootropic Food Ingredients Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Nootropic Food Ingredients Sales Value (2021-2032)
  12. 6.6.2 North America Nootropic Food Ingredients Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Nootropic Food Ingredients Sales Value (2021-2032)
  15. 6.7.2 Europe Nootropic Food Ingredients Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Nootropic Food Ingredients Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Nootropic Food Ingredients Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Nootropic Food Ingredients Sales Value (2021-2032)
  21. 6.9.2 South America Nootropic Food Ingredients Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Nootropic Food Ingredients Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Nootropic Food Ingredients Sales Value Share by Country, 2025 VS 2032
7 Nootropic Food Ingredients Country-level Sales and Value Analysis
  1. 7.1 Global Nootropic Food Ingredients Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Nootropic Food Ingredients Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Nootropic Food Ingredients Sales by Country (2021-2032)
  4. 7.3.1 Global Nootropic Food Ingredients Sales by Country (2021-2026)
  5. 7.3.2 Global Nootropic Food Ingredients Sales by Country (2027-2032)
  6. 7.4 Global Nootropic Food Ingredients Sales Value by Country (2021-2032)
  7. 7.4.1 Global Nootropic Food Ingredients Sales Value by Country (2021-2026)
  8. 7.4.2 Global Nootropic Food Ingredients Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Lonza Group
  2. 8.1.1 Lonza Group Company Information
  3. 8.1.2 Lonza Group Business Overview
  4. 8.1.3 Lonza Group Nootropic Food Ingredients Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Lonza Group Nootropic Food Ingredients Product Portfolio
  6. 8.1.5 Lonza Group Recent Developments
  7. 8.2 DSM Firmenich
  8. 8.2.1 DSM Firmenich Company Information
  9. 8.2.2 DSM Firmenich Business Overview
  10. 8.2.3 DSM Firmenich Nootropic Food Ingredients Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 DSM Firmenich Nootropic Food Ingredients Product Portfolio
  12. 8.2.5 DSM Firmenich Recent Developments
  13. 8.3 Glanbia Nutritionals
  14. 8.3.1 Glanbia Nutritionals Company Information
  15. 8.3.2 Glanbia Nutritionals Business Overview
  16. 8.3.3 Glanbia Nutritionals Nootropic Food Ingredients Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Glanbia Nutritionals Nootropic Food Ingredients Product Portfolio
  18. 8.3.5 Glanbia Nutritionals Recent Developments
  19. 8.4 Kerry Group
  20. 8.4.1 Kerry Group Company Information
  21. 8.4.2 Kerry Group Business Overview
  22. 8.4.3 Kerry Group Nootropic Food Ingredients Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Kerry Group Nootropic Food Ingredients Product Portfolio
  24. 8.4.5 Kerry Group Recent Developments
  25. 8.5 Ingredion Inc
  26. 8.5.1 Ingredion Inc Company Information
  27. 8.5.2 Ingredion Inc Business Overview
  28. 8.5.3 Ingredion Inc Nootropic Food Ingredients Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Ingredion Inc Nootropic Food Ingredients Product Portfolio
  30. 8.5.5 Ingredion Inc Recent Developments
  31. 8.6 Cargill Inc
  32. 8.6.1 Cargill Inc Company Information
  33. 8.6.2 Cargill Inc Business Overview
  34. 8.6.3 Cargill Inc Nootropic Food Ingredients Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Cargill Inc Nootropic Food Ingredients Product Portfolio
  36. 8.6.5 Cargill Inc Recent Developments
  37. 8.7 Indena S.p.A
  38. 8.7.1 Indena S.p.A Company Information
  39. 8.7.2 Indena S.p.A Business Overview
  40. 8.7.3 Indena S.p.A Nootropic Food Ingredients Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Indena S.p.A Nootropic Food Ingredients Product Portfolio
  42. 8.7.5 Indena S.p.A Recent Developments
  43. 8.8 Sabinsa Corporation
  44. 8.8.1 Sabinsa Corporation Company Information
  45. 8.8.2 Sabinsa Corporation Business Overview
  46. 8.8.3 Sabinsa Corporation Nootropic Food Ingredients Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Sabinsa Corporation Nootropic Food Ingredients Product Portfolio
  48. 8.8.5 Sabinsa Corporation Recent Developments
  49. 8.9 Balchem Corporation
  50. 8.9.1 Balchem Corporation Company Information
  51. 8.9.2 Balchem Corporation Business Overview
  52. 8.9.3 Balchem Corporation Nootropic Food Ingredients Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Balchem Corporation Nootropic Food Ingredients Product Portfolio
  54. 8.9.5 Balchem Corporation Recent Developments
  55. 8.10 Givaudan
  56. 8.10.1 Givaudan Company Information
  57. 8.10.2 Givaudan Business Overview
  58. 8.10.3 Givaudan Nootropic Food Ingredients Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Givaudan Nootropic Food Ingredients Product Portfolio
  60. 8.10.5 Givaudan Recent Developments
  61. 8.11 Arla Food Ingredients
  62. 8.11.1 Arla Food Ingredients Company Information
  63. 8.11.2 Arla Food Ingredients Business Overview
  64. 8.11.3 Arla Food Ingredients Nootropic Food Ingredients Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Arla Food Ingredients Nootropic Food Ingredients Product Portfolio
  66. 8.11.5 Arla Food Ingredients Recent Developments
  67. 8.12 PLT Health Solutions
  68. 8.12.1 PLT Health Solutions Company Information
  69. 8.12.2 PLT Health Solutions Business Overview
  70. 8.12.3 PLT Health Solutions Nootropic Food Ingredients Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 PLT Health Solutions Nootropic Food Ingredients Product Portfolio
  72. 8.12.5 PLT Health Solutions Recent Developments
  73. 8.13 Natreon
  74. 8.13.1 Natreon Company Information
  75. 8.13.2 Natreon Business Overview
  76. 8.13.3 Natreon Nootropic Food Ingredients Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Natreon Nootropic Food Ingredients Product Portfolio
  78. 8.13.5 Natreon Recent Developments
  79. 8.14 Kyowa Hakko Bio Co., Ltd
  80. 8.14.1 Kyowa Hakko Bio Co., Ltd Company Information
  81. 8.14.2 Kyowa Hakko Bio Co., Ltd Business Overview
  82. 8.14.3 Kyowa Hakko Bio Co., Ltd Nootropic Food Ingredients Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Kyowa Hakko Bio Co., Ltd Nootropic Food Ingredients Product Portfolio
  84. 8.14.5 Kyowa Hakko Bio Co., Ltd Recent Developments
  85. 8.15 Archer Daniels Midland
  86. 8.15.1 Archer Daniels Midland Company Information
  87. 8.15.2 Archer Daniels Midland Business Overview
  88. 8.15.3 Archer Daniels Midland Nootropic Food Ingredients Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Archer Daniels Midland Nootropic Food Ingredients Product Portfolio
  90. 8.15.5 Archer Daniels Midland Recent Developments
  91. 8.16 BASF SE
  92. 8.16.1 BASF SE Company Information
  93. 8.16.2 BASF SE Business Overview
  94. 8.16.3 BASF SE Nootropic Food Ingredients Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 BASF SE Nootropic Food Ingredients Product Portfolio
  96. 8.16.5 BASF SE Recent Developments
  97. 8.17 Kemin Corporation
  98. 8.17.1 Kemin Corporation Company Information
  99. 8.17.2 Kemin Corporation Business Overview
  100. 8.17.3 Kemin Corporation Nootropic Food Ingredients Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Kemin Corporation Nootropic Food Ingredients Product Portfolio
  102. 8.17.5 Kemin Corporation Recent Developments
  103. 8.18 Ixoreal Biomed
  104. 8.18.1 Ixoreal Biomed Company Information
  105. 8.18.2 Ixoreal Biomed Business Overview
  106. 8.18.3 Ixoreal Biomed Nootropic Food Ingredients Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Ixoreal Biomed Nootropic Food Ingredients Product Portfolio
  108. 8.18.5 Ixoreal Biomed Recent Developments
  109. 8.19 Beijing Gingko Group
  110. 8.19.1 Beijing Gingko Group Company Information
  111. 8.19.2 Beijing Gingko Group Business Overview
  112. 8.19.3 Beijing Gingko Group Nootropic Food Ingredients Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Beijing Gingko Group Nootropic Food Ingredients Product Portfolio
  114. 8.19.5 Beijing Gingko Group Recent Developments
  115. 8.20 Wuxi Cima Science Co., Ltd.
  116. 8.20.1 Wuxi Cima Science Co., Ltd. Company Information
  117. 8.20.2 Wuxi Cima Science Co., Ltd. Business Overview
  118. 8.20.3 Wuxi Cima Science Co., Ltd. Nootropic Food Ingredients Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Wuxi Cima Science Co., Ltd. Nootropic Food Ingredients Product Portfolio
  120. 8.20.5 Wuxi Cima Science Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Nootropic Food Ingredients Value Chain Analysis
  2. 9.1.1 Nootropic Food Ingredients Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Nootropic Food Ingredients Sales Mode & Process
  6. 9.2 Nootropic Food Ingredients Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Nootropic Food Ingredients Distributors
  9. 9.2.3 Nootropic Food Ingredients Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.